Default company panoramic image
C79f0a9d 569f 410f 863e 5a3e1ced37fd

Cascade Biosystems, Inc.

CBI is developing disruptive technology that will revolutionize the DNA assay industry with the potential to replace RTq-PCR technology.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Colfax, WI, USA
  • Currency USD
  • Founded November 2009
  • Employees 2

Company Summary

Cascade Biosystems, Inc. (CBI) is developing core technology for a non-PCR based DNA detection technology we call Restrictase Cascade (RC). RC promises to fulfill a market need to provide low cost and easy to use field deployable molecular diagnostics kits for a wide range of DNA assays ranging from food borne pathogen detection to personalized healthcare assessment needs.


  • Default avatar
    Kenneth Smith

    MBA with expertise is product development and coordinating cross-functional scientific, engineering and business disciplines to support marketing or business level directives. My drive is to invent and problem solve in almost all facets of science and engineering disciplines and thrive in undertaking the most challenging tasks to see ideas from conception to realization.

  • Default avatar
    Mariya Smit

    My expertise is in microbiology, biosensor development, and high-throughput data analyses for microarray and next generation sequencing data. I have over eighteen years (in Japan and United States) of successful post-PhD experience in academia and biotech industry, including fundamental research, student and staff training, technical and customer support.


  • Default avatar
    Patrick Finn III, Ph.D. J.D. - Fish and Richardson, PC
    Default avatar
    Ronald Wetzel, CPA , Arlington Heights, Ill

Previous Investors

  • Default avatar
    Terry Crosby - Angel Investor
    Default avatar
    Qatar National Research Foundation - grant to develop a quick MRSA assay